DPP4 and dementia: CNS engagement relevant to neurodegeneration (class rationale).Observational data associate GLP-1RA exposure with lower risks of several dementias.Target-trial emulation shows no clear overall difference vs. DPP-4 inhibitors; meta-analysis signals possible dementia reduction among cardioprotective agents.Systematic review: metabolic benefits; mixed/negative cognitive and biomarker changes.